Ibex Technologies (TSXV:IBT) EV-to-EBIT : 11.63 (As of May. 17, 2024)

View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ibex Technologies's Enterprise Value is C$28.17 Mil. Ibex Technologies's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was C$2.42 Mil. Therefore, Ibex Technologies's EV-to-EBIT for today is 11.63.

The historical rank and industry rank for Ibex Technologies's EV-to-EBIT or its related term are showing as below:

TSXV:IBT' s EV-to-EBIT Range Over the Past 10 Years
Min: -99999999.99 Med: 2.09 Max: 134.84
Current: 11.63

During the past 13 years, the highest EV-to-EBIT of Ibex Technologies was 134.84. The lowest was -99999999.99. And the median was 2.09.

TSXV:IBT's EV-to-EBIT is ranked worse than
52.9% of 431 companies
in the Biotechnology industry
Industry Median: 10 vs TSXV:IBT: 11.63

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Ibex Technologies's Enterprise Value for the quarter that ended in Jan. 2024 was C$20.33 Mil. Ibex Technologies's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was C$2.42 Mil. Ibex Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 11.91%.

Ibex Technologies EV-to-EBIT Historical Data

The historical data trend for Ibex Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies EV-to-EBIT Chart

Ibex Technologies Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

EV-to-EBIT

Get a 7-Day Free Trial

-0.70

2.57

4.21

1.43

10.66

Ibex Technologies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EV-to-EBIT	Get a 7-Day Free Trial															7.32	7.12	10.66	7.34	8.39

Competitive Comparison of Ibex Technologies's EV-to-EBIT

For the Biotechnology subindustry, Ibex Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ibex Technologies's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's EV-to-EBIT falls into.

Ibex Technologies EV-to-EBIT Calculation

Ibex Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	28.172	/	2.422
	=	11.63

Ibex Technologies's current Enterprise Value is C$28.17 Mil.
Ibex Technologies's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.42 Mil.

Ibex Technologies (TSXV:IBT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ibex Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jan. 2024 )	=	EBIT	/	Enterprise Value (Q: Jan. 2024 )
	=	2.422	/	20.330512
	=	11.91 %

Ibex Technologies's Enterprise Value for the quarter that ended in Jan. 2024 was C$20.33 Mil.
Ibex Technologies's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.42 Mil.

Ibex Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibex Technologies (TSXV:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

IBXNF:USA IBT:Germany

Address

5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7

Website

https://www.ibex.ca

Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines